Jose L. Sandoval - Department of Oncology, Geneva University Hospitals

基本信息

Career Trajectory

Bio

Jose L. Sandoval is a medical doctor and researcher at HUG, Geneva, Switzerland. He has a keen interest in cancer research at several levels (clinical, epidemiological and molecular). Furthermore, he is interested in Global Health and improving cancer care in dIfferent settings.

Research Interests

Papers共 66 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

ESR1 Mutations Emerging During Neoadjuvant Endocrine Therapy in Postmenopausal ER+/HER2-early Breast Cancer Patients: Prevalence and Prognostic Impact

Jose Luis Sandoval, Helene Salaun,Shufang Renault,Marcela Carausu, Aurore Rampanou,Caroline Hego,Matthieu Carton,Luc Cabel, Jean-Yves Pierga,Romain Geiss, Francois-Clement Bidard, Florence Lerebours

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: the Emerging Questions of Sequence and Resistance

Allan Relecom, Francesco Sciotto, Mathieu Chevallier,José Luis Sandoval

healthbook TIMES Oncology Hematology (2024)

Cited0Views0Bibtex

Abstract PO4-15-07: ESR1 mutations emerging during neoadjuvant endocrine therapy in postmenopausal ER+/HER2- early breast cancer patients: prevalence and prognostic impact

José Luis Sandoval,Helene Salaun,Shufang Renault,Marcela Carausu,Aurore Rampanou,Caroline Hego,Matthieu Carton,Luc Cabel,Jean-Yves Pierga,Romain Geiss,Francois-Clement Bidard,Florence Lerebours

Cancer Researchno. 9_Supplement (2024): PO4-15

Cited0Views0Bibtex

Linguistic difference in the effect of organized programs on socioeconomic inequalities in breast cancer screening: ecological study in Switzerland

Clement P Buclin,Martina von Arx,Vladimir Jolidon,José Luis Sandoval, Fabienne Buholzer-Mercier, Justine E Daverio,Bernadette W A van der Linden,Philippe Wanner,Idris Guessous,Delphine S Courvoisier,Stéphane Cullati

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) (2024)

Cited0Views0WOSBibtex

Hematologic Toxicities of Chemotherapy in Breast and Ovarian Cancer Patients Carrying BRCA1/BRCA2 Germline Pathogenic Variants. A Single Center Experience and Review of the Literature

Ketty Hu-Heimgartner,Noemie Lang,Aurelie Ayme,Chang Ming,Jean-Damien Combes,Victor N. Chappuis, Carla Vazquez,Alex Friedlaender,Aurelie Vuilleumier,Alexandre Bodmer,Valeria Viassolo,Jose L. Sandoval,Pierre O. Chappuis,S. Intidhar Labidi-Galy

Familial cancerno. 3 (2023): 283-289

Cited0Views0WOSBibtex

Noemie Lang,Aurelie Ayme,Chang Ming,Jean-Damien Combes,Victor N. Chappuis,Alex Friedlaender,Aurelie Vuilleumier,Jose L. Sandoval,Valeria Viassolo,Pierre O. Chappuis,S. Intidhar Labidi-Galy

Swiss Medical Weeklyno. 3 (2023): 40055-40055

Cited0Views0WOSBibtex

Novel targets for immune-checkpoint inhibition in cancer

Maxime Borgeaud,Jose Sandoval,Michel Obeid,Giuseppe Banna,Olivier Michielin,Alfredo Addeo,Alex Friedlaender

Cancer treatment reviews（2023）

Cited1Views0WOSBibtex

Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection

Dario Trapani,Josè Sandoval,Pamela Trillo Aliaga,Liliana Ascione,Pier Paolo Maria Berton Giachetti,Giuseppe Curigliano,Ophira Ginsburg

Cancer treatment and research (2023): 63-88

Cited0Views0WOSBibtex

Shallow Whole Genome Re-Sequencing to Precisely Predict Benefit from PARP Inhibitor

José Luís Sandoval,Sana Intidhar Labidi‐Galy

Oncogeneno. 48 (2023): 3543-3544

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn